Translation: PhD, full-time researcher, reserve-level talent in Shenzhen, and talent in Futian District, Shenzhen. Principal investigator of the China Postdoctoral Science Foundation and Shenzhen Science and Technology Innovation Committee general projects. Multiple SCI articles published to date, with research findings appearing in internationally renowned journals such as JCI Insight, Cell Death & Disease, and Cancer Biology & Therapy.

September 2006 to June 2010: Bachelor's degree at Southwest University.

September 2010 to January 2016: PhD at Peking University.

July 2016 to December 2018: Postdoctoral researcher at Shenzhen Second People's Hospital.

January 2019 to present: Full-time researcher at Shenzhen Second People's Hospital.

2018 Shenzhen Municipal Science and Technology Innovation Committee Basic Research Project, 100,000 RMB, Principal Investigator.

2017 China Postdoctoral Science Foundation Special Support Fund, 50,000 RMB, Principal Investigator.

（1）Wang, Yujie#; Sun, Qi#; Ye, Ying#; Sun, Xiaoting; Xie, Sisi; Zhan, Yuhang; Song, Jian; Fan, Xiaoqin; Zhang, Bin;Yang, Ming; Lv, Lei; Hosaka, Kayoko; Yang, Yunlong; Nie, Guohui；FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis. JCI insight, 2022, 7(10): e157874.

（2）Sun, Qi#; Wang, Yujie#; Ji Hong#; Sun Xiaoting; Xie Sisi; Chen Longtian; Li Sen; Zeng Weifan; Chen Ruibo; Tang Qi; Zuo Ji; Hou Likun, Hosaka Kayoko; Lu Yongtian; Liu Ying; Ye Ying;Yang Yunlong; Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma, Cell death & disease, 2022, 13:724.

（3）Fan, Xiaoqin#; Wang, Yujie#; Song, Jian; Wu, Hanwei; Yang, Ming; Lu, Lu; Weng, Xin; Liu, Lusha; Nie, Guohui ; MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma, Cancer Biology and Therapy, 2019, 20(10): 1328-1336.

（4）Wang, Yujie#; Wang, Yuyang#; Fan, Xiaoqin; Song, Jian; Wu, Hanwei; Han, Jinghong; Lu, Lu; Weng, Xin; Nie, Guohui; ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma, Biochemical and Biophysical Research Communications, 2018, 503(3):1214-1220.

（5）Song, Jian; Wang, Yujie; Fan, Xiaoqin; Wu, Hanwei; Han, Jinghong; Yang, Ming; Lu, Lu; Nie, Guohui ; Trans-vaccenic acid inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via a mitochondrial-mediated apoptosis pathway, Lipids in Health and Disease,2019, 18: 0-46.

（6）Fan, Xiaoqin; Xie, Xina; Yang, Ming; Wang, Yujie; Wu, Hanwei; Deng, Tingting; Weng, Xin;Wen, Weiping; Nie, Guohui ; YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma via PI3K/AKT Signaling, Frontiers in Oncology, 2021, 11: 0-617621.